<unk>  is an antineoplastic agent that is FDA approved for the treatment of relapsed chronic lymphocytic leukemia,  relapsed follicular b-cell non-hodgkin lymphoma and relapsed small lymphocytic lymphoma. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hyperglycemia, hypertriglyceridemia, abdominal pain, nausea, neutropenia, cough, fatigue, fever and shivering.
Idelalisib
Duvelisib
Alpelisib
Glasdegib
Enasidenib
Vismodegib
Evacetrapib
Ivosidenib